Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums

Elevance Health, Inc. (ELV) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% year over year.See the Zacks Earnings Calendar to stay ahead of market-making news.Operating revenues of $45 billion rose 6% year over year. Moreover, the top line beat the consensus mark by a whisker.Better-than-expected quarterly results benefited from rising premiums and product revenues. Rising expenses and ...